- 专利标题: Dose setting mechanism for a drug delivery device and drug delivery device
-
申请号: US15313905申请日: 2015-05-27
-
公开(公告)号: US10441725B2公开(公告)日: 2019-10-15
- 发明人: Matthew Meredith Jones , Samuel Keir Steel , Neal Alexander Blundred , Joseph Butler , Robert Frederick Veasey , David Plumptre
- 申请人: Sanofi-Aventis Deutschland GmbH
- 申请人地址: DE Frankfurt am Main
- 专利权人: Sanofi-Aventis Deutschland GMBH
- 当前专利权人: Sanofi-Aventis Deutschland GMBH
- 当前专利权人地址: DE Frankfurt am Main
- 代理机构: Fish & Richardson P.C.
- 优先权: EP14170378 20140528
- 国际申请: PCT/EP2015/061632 WO 20150527
- 国际公布: WO2015/181195 WO 20151203
- 主分类号: A61M5/19
- IPC分类号: A61M5/19 ; A61M5/24 ; A61M5/31 ; A61M5/315 ; A61M5/32 ; A61M5/178
摘要:
A dose setting mechanism for a drug delivery device includes a primary drug delivery assembly and a secondary drug delivery assembly. The dose setting mechanism includes a primary dose dial component for setting a dose in the primary drug delivery assembly and a secondary dose dial component for setting a dose in the secondary drug delivery assembly. The primary dose dial component and the secondary dose dial component are configured to rotate during dose setting. A gear mechanism is configured such that in a first phase of the dose setting, rotation of the primary dose dial component is transferred to the secondary dose dial component and such that in a second phase of the dose setting, the secondary dose dial component is decoupled from the primary dose dial component such that rotation of the primary dose dial component is prevented from being transferred to the secondary dose dial component.
公开/授权文献
信息查询
IPC分类: